Като възпрепятства производството на нова ДНК, CellCept намалява скоростта, с която се възпроизвеждат лимфоцитите.
CellCept was compared with azathioprine (another anti-rejection medicine) in all studies except for one of the kidney transplant studies, in which it was compared with placebo (a dummy treatment).